March 14, 2019
Ironwood Announces Effectiveness of Cyclerion Form 10 Registration Statement
– “When-issued” trading of CYCN expected to begin on Nasdaq on March
18, 2019 –
– Separation completion expected April 1, 2019 –
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Ironwood
Pharmaceuticals, Inc. (Nasdaq: IRWD…